Clinical Trials Sponsored by Prilenia

Total 8 results

Prilenia

Completed

Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease (OPEN-HART)

Huntington Disease
Prilenia

Terminated

A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease (Open PRIDE-HD)

Huntington's Disease

United States, Australia, Austria, Canada, France, Germany, Italy, Netherlands, Poland, Russian Federation, United Kingdom
Prilenia

Active, not recruiting

PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD

Huntington Disease

United States, Austria, Canada, Czechia, France, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
Prilenia

Terminated

A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease

Parkinson Disease

United States
Prilenia

Completed

A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's Disease

Health Volunteers, Huntington Disease

Germany
Prilenia
Huntington Study Group; European Huntington's Disease Network

Completed

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Huntington's Disease

United States, Australia, Austria, Canada, Denmark, France, Germany, Italy, Netherlands, Poland, Russian Federation, United Kingdom
Merit E. Cudkowicz, MD
Prilenia Therapeutics

Completed

HEALEY ALS Platform Trial - Regimen D Pridopidine

Amyotrophic Lateral Sclerosis

United States
Prilenia
Massachusetts General Hospital; National Institute of Neurological Disorders... and other collaborators

Available

Pridopidine in Amyotrophic Lateral Sclerosis (EAP 2)

Amyotrophic Lateral Sclerosis

Clinical Trials Sponsored by Prilenia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations